首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   6487篇
  免费   675篇
  国内免费   13篇
耳鼻咽喉   115篇
儿科学   173篇
妇产科学   178篇
基础医学   823篇
口腔科学   108篇
临床医学   899篇
内科学   1197篇
皮肤病学   79篇
神经病学   580篇
特种医学   301篇
外科学   720篇
综合类   98篇
预防医学   813篇
眼科学   122篇
药学   550篇
中国医学   6篇
肿瘤学   413篇
  2021年   93篇
  2020年   61篇
  2019年   84篇
  2018年   111篇
  2017年   83篇
  2016年   79篇
  2015年   120篇
  2014年   134篇
  2013年   192篇
  2012年   275篇
  2011年   282篇
  2010年   196篇
  2009年   184篇
  2008年   261篇
  2007年   299篇
  2006年   270篇
  2005年   273篇
  2004年   235篇
  2003年   256篇
  2002年   218篇
  2001年   198篇
  2000年   236篇
  1999年   224篇
  1998年   108篇
  1997年   109篇
  1996年   110篇
  1995年   77篇
  1994年   66篇
  1993年   94篇
  1992年   159篇
  1991年   174篇
  1990年   173篇
  1989年   166篇
  1988年   156篇
  1987年   141篇
  1986年   143篇
  1985年   116篇
  1984年   80篇
  1983年   75篇
  1982年   73篇
  1981年   64篇
  1980年   63篇
  1979年   66篇
  1978年   49篇
  1977年   37篇
  1976年   38篇
  1975年   40篇
  1974年   36篇
  1973年   37篇
  1972年   41篇
排序方式: 共有7175条查询结果,搜索用时 15 毫秒
11.
Children with no known prior vitamin A deficiency exhibited a significant decline in their serum retinol levels during the acute phase of measles. This decline in circulating retinol was associated with increased duration of fever, higher hospitalization rates, and decreased antibody titers.  相似文献   
12.
13.
1 The standard drug for the treatment of arsenic poisoning is BAL (dimercaprol). BAL possesses marked side-effects and a low safety ratio, drawbacks which new BAL analogues, DMPS and DMSA, do not possess. 2 The efficacy of three chelating agents, BAL, DMPS and DMSA, has been evaluated as a treatment for systemic organic arsenic poisoning, induced by intravenous dichloro(2-chlorovinyl)arsine (lewisite) administration to rabbits. Equimolar dosing schedules were used based upon realistic doses for the most toxic agent, BAL. 3 It was concluded that all three dimercapto chelating agents provided significant protection against the lethal systemic effects of lewisite, and, under the test conditions reported here, there was no significant difference between them in therapeutic efficacy. 4 The cause of mortality following intravenous lewisite in treated and untreated rabbits was pulmonary damage. 5 It is considered that DMPS and DMSA are worthy of further study as replacements for BAL in the treatment of systemic poisoning by lewisite.  相似文献   
14.
15.
16.
N Konishi  T Enomoto  G Buzard  M Ohshima  J M Ward  J M Rice 《Cancer》1992,69(9):2293-2299
Twenty-three clinically silent prostatic carcinomas discovered in Japanese men at autopsy were surveyed for ras proto-oncogene mutations by mutation-specific oligonucleotide probe hybridization after polymerase chain reaction (PCR) amplification from a section of formalin-fixed, paraffin-embedded tissue. Six of the 22 that were satisfactory amplified contained activating point mutations in codon 12 of K-ras, a significantly higher frequency than has been reported in patients with clinically advanced disease in the United States. Of the six cases with activating point mutations in codon 12 of K-ras, one had a GGT----GAT transition, four had GGT----GTT transversions, and one had both GGT----GAT and GGT----GTT mutations. Sections from the same tissues were immunohistochemically stained with an anti-ras p21 antibody. Carcinoma cells stained for ras p21 to some degree in 13 cases. Immunohistochemically detectable expression of p21 was always focal and was not necessarily associated with K-ras mutation. K-ras oncogene activation in prostatic carcinoma appears to merit additional study as a significant event in the pathogenesis of this neoplasm.  相似文献   
17.
Estimated half-lives of mercury following methylmercury exposure in humans are 52-93 d for whole body and 49-164 d for blood. In its most recent 1980 review, the World Health Organization concluded that there was no evidence to suggest that brain half-life differed from whole-body half-life. In the present study, female monkeys (Macaca fascicularis) were dosed for at least 1.7 yr with 10, 25, or 50 micrograms/kg.d of mercury as methylmercuric chloride. Dosing was discontinued, and blood half-life was determined to be about 14 d. Approximately 230 d after cessation of dosing, monkeys were sacrificed and organ and regional brain total mercury levels determined. One monkey that died while still being dosed had brain mercury levels three times higher than levels in blood. Theoretical calculations were performed assuming steady-state brain:blood ratios of 3, 5, or 10. Brain mercury levels were at least three orders of magnitude higher than those predicted by assuming the half-life in brain to be the same as that in blood. Estimated half-lives in brain were between 56 (brain:blood ratio of 3) and 38 (brain:blood ratio of 10) d. In addition, there was a dose-dependent difference in half-lives for some brain regions. These data clearly indicate that brain half-life is considerably longer than blood half-life in the monkey under conditions of chronic dosing.  相似文献   
18.
We examined a nationally representative sample of 60 adult day care centers to describe the state of this evolving care modality after a decade's growth. Results indicate that day care centers can be categorized into three models of care, each of which serves a distinctive subpopulation. Model appropriateness was tested with analysis of variance of differences in participant characteristics. Services, staffing, costs, and other program features are contrasted among the three models.  相似文献   
19.
Basic surgical techniques and variations of endoscopic sinus surgery   总被引:2,自引:0,他引:2  
This article gives complete information on the care of the endoscopic sinus surgery patient. Indications and preoperative evaluations necessary for endoscopic sinus surgery are described. The technique of functional endoscopic sinus surgery is covered in detail. Postoperative care and complications are also described. Various procedures for patients with extensive or unusual disease are discussed.  相似文献   
20.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号